CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Purdue Pharma L.P. v. Acura Pharmaceuticals Inc.

1:16-cv-00256

Overview

Case Number 1:16-cv-00256
Filing Date 2016-04-13
Status Terminated
Termination Date 2016-05-24
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand Plaintiff

Parties

Defendant

Egalet US Inc. Operating Company

Represented By

1 Attorneys Listed

Brian E. Farnan

Farnan LLP

Tel: +1 (302) 777-0300
Fax: +1 (302) 777-0301

919 North Market Street, 12th Floor

Egalet Corporation NPE (Individual / Inventor)

Represented By

1 Attorneys Listed

Brian E. Farnan

Farnan LLP

Tel: +1 (302) 777-0300
Fax: +1 (302) 777-0301

919 North Market Street, 12th Floor

Plaintiff

The P.F. Laboratories Inc. Operating Company

Represented By

2 Attorneys Listed

Jeff Castellano

DLA Piper LLP

Tel: +1 (302) 468-5671

1201 N. Market St., Suite 2100

John W. Shaw

Shaw Keller LLP

Tel: +1 (302) 298-0701

I.M. Pei Building, 1105 North Market Street

Counter Defendant

Purdue Pharmaceuticals L.P. NPE (University / Research)

Represented By

2 Attorneys Listed

Jeff Castellano

DLA Piper LLP

Tel: +1 (302) 468-5671

1201 N. Market St., Suite 2100

John W. Shaw

Shaw Keller LLP

Tel: +1 (302) 298-0701

I.M. Pei Building, 1105 North Market Street

Acura Pharmaceuticals Inc. Operating Company

Represented By

1 Attorneys Listed

Brian E. Farnan

Farnan LLP

Tel: +1 (302) 777-0300
Fax: +1 (302) 777-0301

919 North Market Street, 12th Floor

Purdue Pharma L.P. NPE (University / Research)

Represented By

2 Attorneys Listed

Jeff Castellano

DLA Piper LLP

Tel: +1 (302) 468-5671

1201 N. Market St., Suite 2100

John W. Shaw

Shaw Keller LLP

Tel: +1 (302) 298-0701

I.M. Pei Building, 1105 North Market Street

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 5 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials 1 proceeding
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (5): πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (1 found):
PTAB: 1
USPTO PTAB Trial 2016-04-06
IPR2016-00849

Acura Pharmaceuticals, Inc. et al. v. Purdue Pharma L.P. et al.

U.S. Continuation Sibling (8389007)
Status: Institution Denied
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US9308171
Pharmaceutical formulation containing gelling agent
Filed: 2015-01-30
Issued: 2016-04-12
Active (8.2 yrs remaining)
Expires: 2035-01-30

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Active Threat

Active Threat β€” Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th Year Maintenance Fee Paid (8th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

1

Dispositive

0

Granted

0

Denied

0

Pending / Review

1

Motions by Category

Procedural / Extension Motion 1

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for Defendants to Answer, Move, or Otherwise Respond to the Complaint to 6/6/2016 - filed by Acura Pharmaceuticals Inc., Egalet Corpo...
Entry #5 • 2016-05-04 Document →

Docket Entries

(13 total)
Pleading / Complaint

COMPLAINT filed with Jury Demand against Acura Pharmaceuticals Inc., Egalet Corporation, Egalet US Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1912309.) - filed by Purdue Pharma L.P., The P.F. Laboratories Inc., Purdue Pharmaceuticals L.P..(Attachments: # 1 Exhibit A-D, # 2 Civil Cover Sheet(aah) (Entered: 04/13/2016)

Entry #1 • 2016-04-12
1
Pleading / Complaint

COMPLAINT filed with Jury Demand against Acura Pharmaceuticals Inc., Egalet Corporation, Egalet US Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1912309.) - filed by Purdue Pharma L.P., The P.F. Laboratories Inc., Purdue Pharmaceuticals L.P..(Attachments: # 1 Exhibit A-D, # 2 Civil Cover Sheet(aah) (Entered: 04/13/2016)

Entry #1 • 2016-04-12
2
Pleading / Complaint

COMPLAINT filed with Jury Demand against Acura Pharmaceuticals Inc., Egalet Corporation, Egalet US Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1912309.) - filed by Purdue Pharma L.P., The P.F. Laboratories Inc., Purdue Pharmaceuticals L.P..(Attachments: # 1 Exhibit A-D, # 2 Civil Cover Sheet(aah) (Entered: 04/13/2016)

Entry #1 • 2016-04-12
2

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,308,171 B2;(aah) (Entered: 04/13/2016)

Entry #2 • 2016-04-12
1

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pharmacuetical Research Associates Inc. for The P.F. Laboratories Inc.; Other Affiliate Purdue Pharma L.P. for Purdue Pharmaceuticals L.P.; Other Affiliate Purdue Holding L.P. for Purdue Pharma L.P. filed by Purdue Pharma L.P., Purdue Pharmaceuticals L.P., The P.F. Laboratories Inc.(aah) (Entered: 04/13/2016)

Entry #3 • 2016-04-12
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc